Sale!

EXT1 Gene Chondrosarcoma Familial Genetic Test

Original price was: $700.Current price is: $500.

-29%

The EXT1 Gene Chondrosarcoma Familial NGS Genetic DNA Test is a comprehensive genetic screening that identifies mutations in the EXT1 gene associated with hereditary multiple exostoses and increased chondrosarcoma risk. This advanced next-generation sequencing test provides crucial information for individuals with family history of bone tumors or multiple exostoses. The test helps assess genetic predisposition to chondrosarcoma development, enabling proactive monitoring and early intervention strategies. Results are delivered within 3-4 weeks using blood, extracted DNA, or FTA card samples. Genetic counseling is included to help interpret results and develop personalized management plans. The test costs $500 USD with a regular price of $700 USD, making advanced genetic cancer screening accessible to families across the United States.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

EXT1 Gene Chondrosarcoma Familial NGS Genetic DNA Test

Comprehensive Genetic Screening for Hereditary Bone Cancer Risk

The EXT1 Gene Chondrosarcoma Familial NGS Genetic DNA Test represents a breakthrough in hereditary cancer risk assessment, specifically targeting mutations associated with familial chondrosarcoma predisposition. This advanced diagnostic tool utilizes cutting-edge next-generation sequencing technology to provide comprehensive analysis of the EXT1 gene, which plays a critical role in bone development and tumor suppression.

What Does This Test Measure?

This sophisticated genetic test specifically detects mutations in the EXT1 gene that are known to cause hereditary multiple exostoses (HME), a condition characterized by multiple benign bone tumors called osteochondromas. More importantly, it identifies genetic variants that significantly increase the risk of malignant transformation into chondrosarcoma – a rare but serious form of bone cancer.

  • Comprehensive analysis of the entire EXT1 gene coding region
  • Detection of point mutations, insertions, deletions, and copy number variations
  • Identification of both inherited and de novo genetic variants
  • Assessment of mutation pathogenicity and clinical significance

Who Should Consider This Test?

This genetic screening is particularly important for individuals and families with specific risk factors or clinical presentations:

  • Individuals with personal or family history of multiple exostoses
  • Patients diagnosed with hereditary multiple exostoses (HME)
  • Those with family members affected by chondrosarcoma
  • Individuals presenting with multiple bony growths or osteochondromas
  • Patients with unexplained bone pain or deformities
  • Children showing early signs of skeletal abnormalities
  • Individuals planning family who have concerns about hereditary cancer risk

Clinical Benefits and Importance

Understanding your EXT1 gene status provides numerous clinical advantages for proactive health management:

  • Early Risk Assessment: Identify genetic predisposition before symptoms develop
  • Personalized Monitoring: Establish appropriate surveillance protocols based on genetic risk
  • Family Planning Guidance: Make informed reproductive decisions with genetic counseling
  • Proactive Intervention: Implement early detection strategies for at-risk individuals
  • Treatment Planning: Guide surgical and medical management decisions
  • Psychological Relief: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert team and presented with comprehensive guidance:

  • Positive Result: Indicates the presence of a pathogenic EXT1 mutation, confirming increased chondrosarcoma risk and necessitating regular monitoring
  • Negative Result: No disease-causing mutation detected, significantly reducing hereditary cancer concerns
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing research and periodic re-evaluation
  • Carrier Status: Important information for family planning and genetic counseling purposes

Test Details and Pricing

Test Component Details
Test Name EXT1 Gene Chondrosarcoma Familial NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure accurate results and comprehensive care, we require:

  • Complete clinical history of the patient undergoing testing
  • Genetic counseling session to create detailed family pedigree
  • Documentation of family members affected by EXT1-related conditions
  • Informed consent for genetic testing and result disclosure

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and healthcare providers ensures you receive comprehensive care regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about hereditary cancer risk affect your peace of mind. Our EXT1 Gene Chondrosarcoma Familial NGS Genetic DNA Test provides the clarity you need to make informed healthcare decisions. With advanced technology, expert interpretation, and comprehensive support, we’re here to guide you through every step of your genetic health journey.

Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic cancer risk and protecting your family’s health future.